Logo image of UCL

UCLOUDLINK GROUP INC (UCL) Stock Fundamental Analysis

USA - NASDAQ:UCL - US90354D1046 - ADR

2.21 USD
0 (0%)
Last: 10/17/2025, 11:56:07 AM
Fundamental Rating

3

Overall UCL gets a fundamental rating of 3 out of 10. We evaluated UCL against 22 industry peers in the Wireless Telecommunication Services industry. Both the profitability and the financial health of UCL get a neutral evaluation. Nothing too spectacular is happening here. UCL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year UCL was profitable.
UCL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: UCL reported negative net income in multiple years.
In multiple years UCL reported negative operating cash flow during the last 5 years.
UCL Yearly Net Income VS EBIT VS OCF VS FCFUCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

UCL's Return On Assets of 3.02% is fine compared to the rest of the industry. UCL outperforms 63.64% of its industry peers.
Looking at the Return On Equity, with a value of 8.70%, UCL is in line with its industry, outperforming 59.09% of the companies in the same industry.
UCL has a Return On Invested Capital of 5.00%. This is in the better half of the industry: UCL outperforms 63.64% of its industry peers.
Industry RankSector Rank
ROA 3.02%
ROE 8.7%
ROIC 5%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
UCL Yearly ROA, ROE, ROICUCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

Looking at the Profit Margin, with a value of 2.19%, UCL is in line with its industry, outperforming 54.55% of the companies in the same industry.
UCL's Profit Margin has improved in the last couple of years.
UCL's Operating Margin of 2.19% is on the low side compared to the rest of the industry. UCL is outperformed by 77.27% of its industry peers.
UCL's Operating Margin has declined in the last couple of years.
UCL has a Gross Margin of 48.48%. This is comparable to the rest of the industry: UCL outperforms 40.91% of its industry peers.
In the last couple of years the Gross Margin of UCL has grown nicely.
Industry RankSector Rank
OM 2.19%
PM (TTM) 2.19%
GM 48.48%
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
UCL Yearly Profit, Operating, Gross MarginsUCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

5

2. Health

2.1 Basic Checks

UCL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
UCL has more shares outstanding than it did 1 year ago.
UCL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UCL is higher compared to a year ago.
UCL Yearly Shares OutstandingUCL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
UCL Yearly Total Debt VS Total AssetsUCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

UCL has an Altman-Z score of -1.85. This is a bad value and indicates that UCL is not financially healthy and even has some risk of bankruptcy.
UCL's Altman-Z score of -1.85 is on the low side compared to the rest of the industry. UCL is outperformed by 90.91% of its industry peers.
The Debt to FCF ratio of UCL is 4.22, which is a neutral value as it means it would take UCL, 4.22 years of fcf income to pay off all of its debts.
UCL has a Debt to FCF ratio of 4.22. This is amongst the best in the industry. UCL outperforms 81.82% of its industry peers.
UCL has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.35, UCL belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 4.22
Altman-Z -1.85
ROIC/WACC0.59
WACC8.42%
UCL Yearly LT Debt VS Equity VS FCFUCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.37 indicates that UCL should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.37, UCL is doing good in the industry, outperforming 63.64% of the companies in the same industry.
A Quick Ratio of 1.26 indicates that UCL should not have too much problems paying its short term obligations.
UCL has a better Quick ratio (1.26) than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.26
UCL Yearly Current Assets VS Current LiabilitesUCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. Growth

3.1 Past

The earnings per share for UCL have decreased strongly by -54.55% in the last year.
Measured over the past 5 years, UCL shows a small growth in Earnings Per Share. The EPS has been growing by 3.89% on average per year.
Looking at the last year, UCL shows a small growth in Revenue. The Revenue has grown by 3.72% in the last year.
UCL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.37% yearly.
EPS 1Y (TTM)-54.55%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)3.72%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%-13.33%

3.2 Future

Based on estimates for the next years, UCL will show a very negative growth in Earnings Per Share. The EPS will decrease by -41.98% on average per year.
UCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.48% yearly.
EPS Next Y-116.83%
EPS Next 2Y-41.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.18%
Revenue Next 2Y6.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UCL Yearly Revenue VS EstimatesUCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
UCL Yearly EPS VS EstimatesUCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.20, the valuation of UCL can be described as expensive.
UCL's Price/Earnings ratio is a bit more expensive when compared to the industry. UCL is more expensive than 63.64% of the companies in the same industry.
When comparing the Price/Earnings ratio of UCL to the average of the S&P500 Index (27.29), we can say UCL is valued expensively.
UCL is valuated quite expensively with a Price/Forward Earnings ratio of 54.70.
Based on the Price/Forward Earnings ratio, UCL is valued a bit more expensive than 77.27% of the companies in the same industry.
UCL's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.85.
Industry RankSector Rank
PE 44.2
Fwd PE 54.7
UCL Price Earnings VS Forward Price EarningsUCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UCL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, UCL is valued a bit more expensive than the industry average as 72.73% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 44.05
EV/EBITDA 8.37
UCL Per share dataUCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

UCL's earnings are expected to decrease with -41.98% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)11.37
EPS Next 2Y-41.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for UCL!.
Industry RankSector Rank
Dividend Yield N/A

UCLOUDLINK GROUP INC

NASDAQ:UCL (10/17/2025, 11:56:07 AM)

2.21

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-24 2025-11-24
Inst Owners17.5%
Inst Owner Change0%
Ins Owners8.94%
Ins Owner ChangeN/A
Market Cap83.17M
Analysts80
Price Target8.16 (269.23%)
Short Float %0.43%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)24.75%
Min EPS beat(2)-0.99%
Max EPS beat(2)50.5%
EPS beat(4)2
Avg EPS beat(4)-136.14%
Min EPS beat(4)-692.08%
Max EPS beat(4)98.02%
EPS beat(8)5
Avg EPS beat(8)-6.44%
EPS beat(12)7
Avg EPS beat(12)-5.65%
EPS beat(16)8
Avg EPS beat(16)-89.12%
Revenue beat(2)1
Avg Revenue beat(2)-7.3%
Min Revenue beat(2)-16.59%
Max Revenue beat(2)2%
Revenue beat(4)2
Avg Revenue beat(4)-4.16%
Min Revenue beat(4)-16.59%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-3.27%
Revenue beat(12)5
Avg Revenue beat(12)-2.9%
Revenue beat(16)7
Avg Revenue beat(16)-1.97%
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-66.67%
EPS NY rev (1m)-300%
EPS NY rev (3m)-300%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.45%
Valuation
Industry RankSector Rank
PE 44.2
Fwd PE 54.7
P/S 0.93
P/FCF 44.05
P/OCF 44.05
P/B 3.7
P/tB 3.79
EV/EBITDA 8.37
EPS(TTM)0.05
EY2.26%
EPS(NY)0.04
Fwd EY1.83%
FCF(TTM)0.05
FCFY2.27%
OCF(TTM)0.05
OCFY2.27%
SpS2.37
BVpS0.6
TBVpS0.58
PEG (NY)N/A
PEG (5Y)11.37
Profitability
Industry RankSector Rank
ROA 3.02%
ROE 8.7%
ROCE 8.53%
ROIC 5%
ROICexc N/A
ROICexgc N/A
OM 2.19%
PM (TTM) 2.19%
GM 48.48%
FCFM 2.11%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
F-Score4
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 4.22
Debt/EBITDA 1.86
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 44.05%
Profit Quality 96.67%
Current Ratio 1.37
Quick Ratio 1.26
Altman-Z -1.85
F-Score4
WACC8.42%
ROIC/WACC0.59
Cap/Depr(3y)133.27%
Cap/Depr(5y)103.42%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.55%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-66.67%
EPS Next Y-116.83%
EPS Next 2Y-41.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.72%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%-13.33%
Revenue Next Year-6.18%
Revenue Next 2Y6.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-53.65%
EBIT growth 3YN/A
EBIT growth 5Y-12.3%
EBIT Next Year25.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.5%
FCF growth 3YN/A
FCF growth 5Y12.11%
OCF growth 1Y-83.5%
OCF growth 3YN/A
OCF growth 5Y9.78%